SEC Company Response from BICYCLE THERAPEUTICS PLC (BCYC) (CIK 0001761612) (BCYC) — May 20, 2019
BICYCLE THERAPEUTICS PLC (BCYC) (CIK 0001761612)
Date: May 20, 2019 · CIK: 0001761612 · Accession: 0001104659-19-030540
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-231076
Letter
VIA EDGAR Acceleration Request Requested Date: May 22, 2019 Requested Time: 4:00 p.m., Eastern Time
Re: Bicycle Therapeutics Ltd. Acceleration Request for Registration Statement on Form S-1 File No. 333-231076
Dear Mr. Edwards and Ms. Walsh:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Bicycle Therapeutics Ltd. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to May 22, 2019, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP by calling James Xu at (617) 570-1483. We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin Procter LLP, Attention: James Xu, by facsimile to (617) 801-8920 or by email at JXu@goodwinlaw.com.
[Remainder of page left intentionally blank]
If you have any questions regarding this request, please contact James Xu of Goodwin Procter LLP at (617) 570-1483.
Sincerely,
Bicycle Therapeutics Ltd.
Show Raw Text
CORRESP 1 filename1.htm VIA EDGAR May 20, 2019 U.S. Securities and Exchange Commission Division of Corporation Finance Mail Stop 4561 100 F Street, N.E. Washington, D.C. 20549 Attention: Chris Edwards and Liz Walsh Re: Bicycle Therapeutics Ltd. Acceleration Request for Registration Statement on Form S-1 File No. 333-231076 Acceleration Request Requested Date: May 22, 2019 Requested Time: 4:00 p.m., Eastern Time Dear Mr. Edwards and Ms. Walsh: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Bicycle Therapeutics Ltd. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to May 22, 2019, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP by calling James Xu at (617) 570-1483. We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin Procter LLP, Attention: James Xu, by facsimile to (617) 801-8920 or by email at JXu@goodwinlaw.com. [Remainder of page left intentionally blank] If you have any questions regarding this request, please contact James Xu of Goodwin Procter LLP at (617) 570-1483. Sincerely, Bicycle Therapeutics Ltd. /s/ Kevin Lee Kevin Lee, Ph.D., MBA Chief Executive Officer cc: Kevin Lee, Bicycle Therapeutics Limited Lee Kalowski, Bicycle Therapeutics Limited Kristopher D. Brown, Goodwin Procter LLP Jonathan A. Schur, Goodwin Procter LLP Divakar Gupta, Cooley LLP Ryan Sansom, Cooley LLP Richard Segal, Cooley LLP 2